|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 579-584, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
B Koul, P Wollmer, H Willen, J Kugelberg and S Steen
This study was undertaken to find out if about 25% right cardiac output is
sufficient for preservation of lung function during prolonged periods of
venoarterial extracorporeal membrane oxygenation. Six healthy pigs weighing
57 kg were subjected to 18-hour venoarterial extracorporeal membrane
oxygenation. During this period 1200 ml/min venous blood was delivered to
the lungs through the pulmonary artery with the help of a separate roller
pump and with use of the animal's own right ventricle to generate the
pulse. Animals were observed for 6 hours after weaning from the
venoarterial extracorporeal membrane oxygenation. At the sixth hour after
extracorporeal membrane oxygenation, arterial oxygen tension, venous oxygen
tension, lung compliance, and cardiac output had decreased significantly.
Pulmonary vascular resistance and pulmonary clearance of technetium 99m-
diethylenetriamine pentaacetic acid increased significantly also. The
systemic arterial and venous carbon dioxide tensions, pH, and the base
excess remained unchanged, as did the blood pressure and the systemic
vascular resistance. Histopathology of the lung specimens revealed focal
alveolar wall thickening and alveolar capillary congestion. The major
portion of the pulmonary parenchyma looked normal. Alterations in pulmonary
parameters cited were, to a major extent, explained on the basis of the
experimental protocol followed and were believed to be reversible. This
study suggests that about 25% of the systemic cardiac output should be
diverted into the pulmonary artery for prevention of irreversible
physiologic and histopathologic changes in the lungs during 18-hour
normothermic venoarterial extracorporeal membrane oxygenation in healthy
juvenile pigs.
ARTICLES
Venoarterial extracorporeal membrane oxygenation--how safe is it? Evaluation with a new experimental model
Thoracic Surgical Clinic, University Hospital, Lund, Sweden.
This article has been cited by other articles:
![]() |
L. G. Fischer, H. V. Aken, and H. Burkle Management of Pulmonary Hypertension: Physiological and Pharmacological Considerations for Anesthesiologists Anesth. Analg., June 1, 2003; 96(6): 1603 - 1616. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |